Cellbricks is a startup based in Germany. Brouky records 1 investor associated with the company.
Cellbricks develops a patented bioprinting process to manufacture in‑vitro tissue models, personalized implants and organ-replacement constructs by printing multiple cell types into tissue-like structures with integrated vasculature.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.